Applicability and results of liver transplant combined with neoadjuvant chemo-radiotherapy in the treatment of unresectable hilar cholangiocarcinoma.

Cirugía española
Cristina DopazoR Charco

Abstract

In 2007, a multicenter protocol was developed in Catalonia, Spain, combining neoadjuvant chemoradiotherapy and liver transplantation (LT) for those patients with unresectable hilar cholangiocarcinoma (hCCA). To analyse the effectiveness of the neoadjuvant chemoradiotherapy and LT for those patients enrolled in the protocol based on intention-to-treat. Observational multicenter study which includes patients ≤ 68 years-old diagnosed with unresectable, solitary tumors ≤ 3 cm in radial diameter, without evidence of lymph node metastases. The protocol was based on a strategy of neoadjuvant therapy with high-dose radiation (45 Gy in total) plus intravenous fluorouracil (5-FU) given as a daily bolus for the first 3 days of radiation follow by oral capecitabine until transplantation. The patient was included in waiting list for LT if no evidence of disseminated disease was found. Between 2007 and 2018, 13 patients were enrolled in the transplant protocol. Of those, 61% (8/13) of the patients were transplanted. The average time spent on the waiting list was 122 days (range 5-192). Intent-to-treat survival was 69% and 39% at one and 5 years. Post-transplantation overall survival was 87% and 62% and 29% recurrence rate at 5 years. The sui...Continue Reading

References

Feb 1, 1988·World Journal of Surgery·H BismuthO Traynor
May 29, 2000·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·I De VreedeG J Gores
Apr 24, 2001·The American Journal of Gastroenterology·M KayaK D Lindor
Sep 27, 2001·Annals of Surgery·W R JarnaginL H Blumgart
Feb 28, 2003·Surgical Oncology Clinics of North America·Ziad HassounCharles B Rosen
Jan 28, 2004·Annals of Surgery·Ricardo RoblesPascual Parrilla
Jun 12, 2004·Seminars in Liver Disease·Julie K HeimbachCharles B Rosen
Oct 7, 2009·Journal of Hepato-biliary-pancreatic Sciences·Flavio G RochaWilliam R Jarnagin
Oct 31, 2009·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Daniel SeehoferPeter Neuhaus
Jul 4, 2012·Journal of the American College of Surgeons·Kenichi MatsuoWilliam R Jarnagin
Jul 17, 2012·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·Min Soo ChoKyung Sik Kim
Nov 6, 2012·The British Journal of Surgery·O FargesJ F Gigot
Apr 16, 2015·Journal of the American College of Surgeons·Kristopher P CroomeDavid M Nagorney
Jul 15, 2015·HPB : the Official Journal of the International Hepato Pancreato Biliary Association·John C MansourJean-Nicolas Vauthey
Oct 12, 2015·Journal of the American College of Surgeons·Bas Groot KoerkampThomas M van Gulik
Sep 25, 2016·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J W ValleUNKNOWN ESMO Guidelines Committee
Nov 26, 2018·Surgery·Taizo Hibi, Gonzalo Sapisochin
Feb 11, 2020·JHEP Reports : Innovation in Hepatology·Phillipe AbreuGonzalo Sapisochin

❮ Previous
Next ❯

Citations

Aug 8, 2021·International Journal of Molecular Sciences·Alessio MalacridaMariarosaria Miloso

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.